GB/T 38792-2020
ActiveTechnical specification for cytological evaluation of protein allergenicity
蛋白质致敏性细胞学评价技术规范
Application Summary AI generated
This standard specifies in vitro cell-based methods for evaluating the allergenic potential of proteins, focusing on immune cell activation and mediator release assays. It is applied in the food, biotechnology, and pharmaceutical industries to assess the safety of novel proteins, such as those from genetically modified organisms or alternative protein sources, during product development and regulatory approval processes.
Related Standards
NY/T 702-2003
Hop
NY 626-2002
Shennong synthetic line pig
NY 624-2002
Jun Mu No. 1 white pig
NY/T 629-2002
Propolis
NY 625-2002
Composite line DEKALB breeding pig
NY 623-2002
Inner Mongolia Cashmere Goat
GB/Z 44313-2024
Biotechnology—Biobanking—Requirements for the biobanking of plant biological material for research and development
GB/Z 44314-2024
Biotechnology—Biobanking—Requirements for the biobanking of animal biological material
Transparency note: The application summary and key sentences on this page were automatically generated by AI from the standard's original text. This content has not been human-verified and should not be used for compliance or regulatory purposes. Always refer to the official standard document from the issuing authority.